Latest Photos
Introduction
Yorkshire Biotec has two main areas of operations, firstly the development of novel drug delivery systems for existing pharmaceutical products to meet unmet medical need, and secondly the provision of contract laboratory services.
This duality of focus enables Yorkshire Biotec to and fund its development opportunities through the provision of service and ensure that in-house R&D facilities are available to realise commercial opportunities that present themselves in a fast and efficient manner.
This duality of focus enables Yorkshire Biotec to and fund its development opportunities through the provision of service and ensure that in-house R&D facilities are available to realise commercial opportunities that present themselves in a fast and efficient manner.
Contact Info
Address:
9 Comet Court
Auckley
South Yorkshire DN9 3PY
United Kingdom
Auckley
South Yorkshire DN9 3PY
United Kingdom
Tel:
02081444960
Website:
http://www.yorkshirebiotec.co.uk
Hours of operation
| From | To | From | To | From | To | ||
|---|---|---|---|---|---|---|---|
| Monday | Open | 9 | 5 | ||||
| Tuesday | Open | 9 | 5 | ||||
| Wednesday | Open | 9 | 5 | ||||
| Thursday | Open | 9 | 5 | ||||
| Friday | Open | 9 | 5 | ||||
| Saturday | Open | ||||||
| Sunday | Open | ||||||
Meet Our Team (2)
Damien Bove
Director of Product Development
Damien has worked in the pharmaceutical industry for over 19 years, first as a pharmaceutical technician, and then as an academic research manager at SmithKline Beecham before completing his university education. Damien graduated from the University of Bradford School of Pharmacy in 2000 and has a Master’s degree in the Frontiers of Medical Science. He has since pursued his career in the development of novel drug/biological products.
Damien started his post-university career working at Covance, a global contract research organisation. He worked in the global consultancy division in the area of emergent product services, specialising in defining markets and regulatory/ development strategies for novel pharmaceutical and biotechnology products. In 2004, Damien became an independent consultant in this area, specialising in working with virtual and small drug development companies.
His work has seen him frequently working with regulatory agencies across the globe in order to fast-track products into Man, he develops strategies and works within the regulatory structures of the FDA, EMA, MHRA and Health Canada, amongst others. Damien also organises courses on The Regulations of First in Man Clinical Trials and Business Planning for MedTech Entrepreneurs
Damien started his post-university career working at Covance, a global contract research organisation. He worked in the global consultancy division in the area of emergent product services, specialising in defining markets and regulatory/ development strategies for novel pharmaceutical and biotechnology products. In 2004, Damien became an independent consultant in this area, specialising in working with virtual and small drug development companies.
His work has seen him frequently working with regulatory agencies across the globe in order to fast-track products into Man, he develops strategies and works within the regulatory structures of the FDA, EMA, MHRA and Health Canada, amongst others. Damien also organises courses on The Regulations of First in Man Clinical Trials and Business Planning for MedTech Entrepreneurs
Tom Chapman
MD
Damien has worked in the pharmaceutical industry for over 19 years, first as a pharmaceutical technician, and then as an academic research manager at SmithKline Beecham before completing his university education. Damien graduated from the University of Bradford School of Pharmacy in 2000 and has a Master’s degree in the Frontiers of Medical Science. He has since pursued his career in the development of novel drug/biological products.
Damien started his post-university career working at Covance, a global contract research organisation. He worked in the global consultancy division in the area of emergent product services, specialising in defining markets and regulatory/ development strategies for novel pharmaceutical and biotechnology products. In 2004, Damien became an independent consultant in this area, specialising in working with virtual and small drug development companies.
His work has seen him frequently working with regulatory agencies across the globe in order to fast-track products into Man, he develops strategies and works within the regulatory structures of the FDA, EMA, MHRA and Health Canada, amongst others. Damien also organises courses on The Regulations of First in Man Clinical Trials and Business Planning for MedTech Entrepreneurs
Damien started his post-university career working at Covance, a global contract research organisation. He worked in the global consultancy division in the area of emergent product services, specialising in defining markets and regulatory/ development strategies for novel pharmaceutical and biotechnology products. In 2004, Damien became an independent consultant in this area, specialising in working with virtual and small drug development companies.
His work has seen him frequently working with regulatory agencies across the globe in order to fast-track products into Man, he develops strategies and works within the regulatory structures of the FDA, EMA, MHRA and Health Canada, amongst others. Damien also organises courses on The Regulations of First in Man Clinical Trials and Business Planning for MedTech Entrepreneurs
